Workflow
ACADIA Pharmaceuticals (NasdaqGS:ACAD) FY Conference Transcript

ACADIA Pharmaceuticals (NasdaqGS:ACAD) FY Conference September 08, 2025 10:45 AM ET Company ParticipantsMark Schneyer - CFOElizabeth H.Z. Thompson - EVP, Head - Research & DevelopmentCatherine Owen Adams - CEO & DirectorConference Call ParticipantsSean Laaman - Research Analyst - Biotechnology Small & MidcapSean LaamanGood morning, everyone. Welcome to the Morgan Stanley Global Healthcare Conference. I'm Sean Lahman, Head of U.S. Mid-Cap Biotech Equity Research here at the firm. For important disclosures, p ...